Kenneth D Aldape - JoVE Visualize

Showing results (121-130 of 192) with videos related to

Pageof 20

Sort By:

Neuro-Oncology|August 30, 2024

cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomasFelix Sahm, Kenneth D Aldape, Priscilla K Brastianos, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006

Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapyKelly N Blehm, Philippe E Spiess, Jolanta E Bondaruk, et al.

American Journal of Clinical Pathology|April 29, 2016

Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid TumorsRashmi S Goswami, Rajyalakshmi Luthra, Rajesh R Singh, et al.

The American Journal of Surgical Pathology|October 30, 2023

Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential DiagnosisJerzy Lasota, Małgorzata Chłopek, Maciej Kaczorowski, et al.

The Journal of Pathology. Clinical Research|August 9, 2016

Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomasKanishka Sircar, Suk-Young Yoo, Tadeusz Majewski, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007

Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium studyMonica E Loghin, Michael D Prados, Patrick Wen, et al.

Plos One|March 12, 2014

Molecular subtypes of glioblastoma are relevant to lower grade gliomaXiaowei Guan, Jaime Vengoechea, Siyuan Zheng, et al.

Neuro-Oncology|December 6, 2013

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resectionJason Beiko, Dima Suki, Kenneth R Hess, et al.

Acta Neuropathologica|February 22, 2015

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomasAdriana Olar, Khalida M Wani, Kristin D Alfaro-Munoz, et al.

Pageof 20

Showing results (121-130 of 192) with videos related to

Sort By:

Pageof 20

Neuro-Oncology|August 30, 2024

cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomasFelix Sahm, Kenneth D Aldape, Priscilla K Brastianos, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006

Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapyKelly N Blehm, Philippe E Spiess, Jolanta E Bondaruk, et al.

American Journal of Clinical Pathology|April 29, 2016

Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid TumorsRashmi S Goswami, Rajyalakshmi Luthra, Rajesh R Singh, et al.

The American Journal of Surgical Pathology|October 30, 2023

Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential DiagnosisJerzy Lasota, Małgorzata Chłopek, Maciej Kaczorowski, et al.

The Journal of Pathology. Clinical Research|August 9, 2016

Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomasKanishka Sircar, Suk-Young Yoo, Tadeusz Majewski, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007

Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium studyMonica E Loghin, Michael D Prados, Patrick Wen, et al.

Plos One|March 12, 2014

Molecular subtypes of glioblastoma are relevant to lower grade gliomaXiaowei Guan, Jaime Vengoechea, Siyuan Zheng, et al.

Neuro-Oncology|December 6, 2013

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resectionJason Beiko, Dima Suki, Kenneth R Hess, et al.

Acta Neuropathologica|February 22, 2015

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomasAdriana Olar, Khalida M Wani, Kristin D Alfaro-Munoz, et al.

Pageof 20